Health Care & Life Sciences » Pharmaceuticals | Moberg Pharma AB

Moberg Pharma AB | Cash Flow

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
14,056.00
17,231.00
35,183.00
62,171.00
51,073.00
64,819
Depreciation, Depletion & Amortization
6,105.00
8,068.00
11,216.00
15,734.00
38,367.00
36,925
Other Funds
-
-
-
6,338.00
-
45,324
Funds from Operations
8,250.00
24,064.00
47,315.00
26,503.00
41,797.00
56,420
Changes in Working Capital
5,100.00
7,902.00
16,596.00
44,444.00
12,022.00
17,471
Net Operating Cash Flow
3,150.00
16,162.00
30,719.00
17,941.00
53,819.00
73,891
Capital Expenditures
30,500.00
7,272.00
43,883.00
680,656.00
73,472.00
Net Investing Cash Flow
47,158.00
24,497.00
43,883.00
680,656.00
19,677.00
Issuance/Reduction of Debt, Net
10,000.00
13,333.00
13,333.00
577,925.00
-
Net Financing Cash Flow
24,049.00
42,604.00
4,211.00
737,952.00
858.00
Net Change in Cash
26,285.00
35,325.00
17,107.00
40,748.00
33,333.00
Free Cash Flow
3,351.00
16,120.00
30,365.00
18,196.00
53,437.00
Net Assets from Acquisitions
16,658.00
17,225.00
-
-
-
Other Sources
-
-
-
-
53,795.00
Change in Capital Stock
34,049.00
55,937.00
9,122.00
153,689.00
858.00
Exchange Rate Effect
26.00
1,056.00
268.00
1,393.00
1,667.00

About Moberg Pharma AB

View Profile
Address
Gustavslundsvägen 42, 5 tr
Bromma AB 167 51
Sweden
Employees -
Website http://www.mobergpharma.se
Updated 07/08/2019
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.